InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+96.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Desjardins Clarissa, 董事. Officer active across 3 companies, notably INSMED Inc. Aggregated, 7 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €112k. History available since 20 May 2025. The latest transaction was disclosed on 20 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Desjardins Clarissa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,305 股Common StockSEC:0001793390-26-000002:0
1,895 股@ US$66.87100.0% 占其流量Common StockSEC:0001628280-25-027340:0
标准退出：2025年8月18日 (T+90)
5,058 股Common StockSEC:0001628280-25-026567:0
13,162 股Common StockSEC:0001628280-24-023562:0
13,192 股Common StockSEC:0001628280-23-018201:0
14,645 股Common StockSEC:0001140361-22-019181:0
7,558 股Common StockSEC:0001140361-21-017415:0
7 条申报中的 7 条
About Desjardins Clarissa
Clarissa Desjardins is a Board Member at INSMED Inc. She contributes to the company's governance and strategic decision-making. Desjardins is recognized for her expertise in the biopharmaceutical sector and her commitment to innovation. Her role is essential in guiding INSMED toward sustainable and responsible growth.
